ProducsDistribution Products

BRAMITOB

Therapeutic indication:

Management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 6 years and older.

  • Composition: Each 4 ml single-dose container contains tobramycin 300 mg.
  • Pharmaceutical form: Nebulizer solution
  • Method of administration: Nebulization
  • Manufacturer: Chiesi